首页> 外文OA文献 >Cost-effectiveness of CT angiography and perfusion imaging for delayed cerebral ischemia and vasospasm in aneurysmal subarachnoid hemorrhage
【2h】

Cost-effectiveness of CT angiography and perfusion imaging for delayed cerebral ischemia and vasospasm in aneurysmal subarachnoid hemorrhage

机译:CT血管造影和灌注成像在动脉瘤性蛛网膜下腔出血中延迟性脑缺血和血管痉挛的成本效益

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

textabstractBACKGROUND AND PURPOSE: Delayed cerebral ischemia and vasospasm are significant complications following SAH leading to cerebral infarction, functional disability, and death. In recent years, CTA and CTP have been used to increase the detection of delayed cerebral ischemia and vasospasm. Our aim was to perform comparative-effectiveness and cost-effectiveness analyses evaluating CTA and CTP for delayed cerebral ischemia and vasospasm in aneurysmal SAH from a health care payer perspective. MATERIALS AND METHODS: We developed a decision model comparing CTA and CTP with transcranial Doppler sonography for detection of vasospasm and delayed cerebral ischemia in SAH. The clinical pathways were based on the "Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association" (2012). Outcome health states represented mortality and morbidity according to functional outcomes. Input probabilities of symptoms and serial test results from CTA and CTP, transcranial Doppler ultrasound, and digital subtraction angiography were directly derived from an SAH cohort by using a multinomial logistic regression model. Expected benefits, measured as quality-adjusted life years, and costs, measured in 2012 US dollars, were calculated for each imaging strategy. Univariable, multivariable, and probabilistic sensitivity analyses were performed to determine the independent and combined effect of input parameter uncertainty. RESULTS: The transcranial Doppler ultrasound strategy yielded 13.62 quality-adjusted life years at a cost of $154,719. The CTA and CTP strategy generated 13.89 quality-adjusted life years at a cost of $147,097, resulting in a gain of 0.27 quality-adjusted life years and cost savings of $7622 over the transcranial Doppler ultrasound strategy. Univariable and multivariable sensitivity analyses indicated that results were robust to plausible input parameter uncertainty. Probabilistic sensitivity analysis results yielded 96.8% of iterations in the right lower quadrant, representing higher benefits and lower costs. CONCLUSIONS: Our model results suggest that CTA and CTP are the preferred imaging strategy in SAH, compared with transcranial Doppler ultrasound, leading to improved clinical outcomes and lower health care costs.
机译:目的和目的:延迟性脑缺血和血管痉挛是SAH引起的严重并发症,导致脑梗塞,功能障碍和死亡。近年来,CTA和CTP已用于增加对延迟性脑缺血和血管痉挛的检测。我们的目标是从医疗保健付款人的角度进行比较有效性和成本效益分析,评估CTA和CTP对动脉瘤SAH中延迟性脑缺血和血管痉挛的作用。材料与方法:我们开发了一种决策模型,将CTA和CTP与经颅多普勒超声检查相比较,以检测SAH中的血管痉挛和延迟性脑缺血。临床途径基于“动脉瘤性蛛网膜下腔出血的治疗指南:美国心脏协会/美国中风协会的医疗保健专业人员指南”(2012年)。根据功能结果,结果健康状态代表死亡率和发病率。通过使用多项逻辑回归模型,可以从SAH队列中直接得出CTA和CTP,经颅多普勒超声和数字减影血管造影术的症状输入概率和系列检测结果。计算每种成像策略的预期收益(以质量调整生命年为单位)和成本(以2012年美元为单位)。进行了单变量,多变量和概率敏感性分析,以确定输入参数不确定性的独立和组合影响。结果:经颅多普勒超声检查策略产生的质量调整生命年为13.62年,费用为154,719美元。与经颅多普勒超声策略相比,CTA和CTP策略产生了13.89个质量调整后的生命年,成本为147,097美元,从而获得了0.27个质量调整后的生命年,并且节省了7622美元的成本。单变量和多变量灵敏度分析表明,结果对于合理的输入参数不确定性具有鲁棒性。概率敏感性分析结果在右下象限产生了96.8%的迭代,代表了更高的收益和更低的成本。结论:我们的模型结果表明,与经颅多普勒超声检查相比,CTA和CTP是SAH中首选的影像学策略,从而改善了临床疗效并降低了医疗费用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号